US9481692B2

Heterocyclic modulators of HIF activity for treatment of disease

University of Texas System

Abstract

The present invention relates to compounds and methods which may be useful as inhibitors of HIF pathway activity for the treatment or prevention of cancer and other hypoxia-mediated diseases.

University: University of Texas System
Assignee: Board Of Regents, The University Of Texas System
Inventor: Philip Jones
Priority date: August 24, 2012
Filing date: March 12, 2015
Grant date: November 01, 2016
Publication date: November 01, 2016
Language: en
PDF source: https://patentimages.storage.googleapis.com/72/7c/4c/52a9a53672eda0/US9481692.pdf
Metadata fetched: August 29, 2026 00:23